SynthesisFrontiers in oncology2025
Efficacy and safety of male fertility-sparing radical cystectomy with orthotopic neobladder versus radical cystectomy and nerve-sparing cystectomy: a meta-analysis.
Synthesis in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Radical cystectomy (RC) serves as the gold standard treatment for organ-localized bladder cancer; however, postoperative complications diminish the quality of life of patients. Whether male fertility-sparing radical cystectomy(FSRC) with orthotopic neobladder (ONB) surpasses RC and nerve-sparing cystectomy (NSC) remains controversial. The objective of this study is to compare the efficacy and safety of the two surgical approaches. Methods: In accordance with the PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analysis) statement, PubMed, Web of Science, Embase, CNKI databases, Medline, and Cochrane Library were searched until June 2024. Eligible studies were identified in line with the inclusion and exclusion criteria. Results: A total of 10 studies encompassing 1104 patients were incorporated in this study. The outcomes demonstrated that fertility-sparing radical cystectomy (FSRC) presented significant superiority in erectile function (EF) (OR: 12.67; 95% CI 3.27-49.03; P<0.001), daytime urinary continence (OR: 5.91; 95% CI, 1.83-19.13; P = 0.003), and nocturnal urinary continence (OR: 5.13; 95% CI, 1.98-13.34; P<0.001) over non-fertility-sparing radical cystectomy (nFSRC). Compared with nFSRC, the incidences of postoperative prostate cancer (RD:-0.10; 95% CI, -0.21-0.10; P = 0.086), tumor local recurrence (OR:0.51; 95% CI, 0.26-1.00; P = 0.052), tumor metastasis (RD:-0.02; 95% CI, -0.09-0.06; P = 0.665) and 2-year survival (OR:1.21; 95% CI, 0.63-2.30; P = 0.567) after surgery were comparable. In the subgroup analysis, some differences in outcome measures were identified based on sample size, study type, control group, and study area. Conclusion: Under rigorous preoperative screening, male FSRC with ONB demonstrates certain efficacy and safety in the treatment of bladder cancer, particularly among younger patients, warranting broader clinical consideration. More relevant clinical RCTs are required. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD42024558576.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.